There was no statistically significant difference between the 2 groups in the early mortality rate : 19 ( 27.1 % ) of 70 ribavirin recipients and 21 ( 25.3 % ) of 83 placebo recipients died ( odds ratio , 1.10 ; 95 % confidence interval , 0.5-2 .4 ) .
